Of major relevance, a growing body of literature indicates that the success of a variety of anti-cancer treatments implicates the induction of type I IFN signaling and shows that intra- and peri-tumoral expression levels of type I IFNs and IFN-stimulated genes correlate with favorable disease outcome in several cohorts of cancer patients [16,17,18]. Here, IFNA1 is linked to cancer.